НовостиBenzingaWells Fargo Maintains Overweight on BeOne Medicines, Raises Price Target to $435 Wells Fargo Maintains Overweight on BeOne Medicines, Raises Price Target to $435 Benzinga 2026.11.06 14:52 (GMT+0) Открыть на Benzinga Другие новости